Profil
Kazuo Yamamoto is currently the President & Representative Director at Immunas Pharma, Inc. since 2017.
He is also the Representative Director at Laboratoires OncoTherapy Science France SARL since 2014.
Previously, he worked as the Director, GM-Administration & IR Contact at OncoTherapy Science, Inc. from 2008 to 2014.
Postes actifs de Kazuo Yamamoto
| Sociétés | Poste | Début |
|---|---|---|
Immunas Pharma, Inc.
 Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | President | 01/02/2017 |
| Laboratoires OncoTherapy Science France SARL | Directeur/Membre du Conseil | 01/08/2014 |
Anciens postes connus de Kazuo Yamamoto
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | President | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
| Laboratoires OncoTherapy Science France SARL |
